AMPH icon

Amphastar Pharmaceuticals

222 hedge funds and large institutions have $1.06B invested in Amphastar Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 90 increasing their positions, 74 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more ownership

Funds ownership:

1% less capital invested

Capital invested by funds: $1.07B → $1.06B (-$7.7M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

90% less call options, than puts

Call options by funds: $6.06M | Put options by funds: $60.7M

Holders
222
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.06M
Puts
$60.7M
Net Calls
Net Calls Change

Top Buyers

1 +$9.56M
2 +$9.2M
3 +$7.62M
4
Goldman Sachs
Goldman Sachs
New York
+$7.42M
5
CM
Castleark Management
Illinois
+$6.7M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$531K
127
$530K
128
$485K
129
$483K
130
$481K
131
$471K
132
$452K
133
$452K
134
$435K
135
$430K
136
$429K
137
$429K
138
$428K
139
$422K
140
$414K
141
$409K
142
$396K
143
$391K
144
$387K
145
$379K
146
$366K
147
$361K
148
$343K
149
$341K
150
$319K